Liquidia Corp (LQDA)
13.21
+0.47
(+3.69%)
USD |
NASDAQ |
May 20, 12:28
Liquidia Revenue (Annual): 17.49M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.49M |
| December 31, 2022 | 15.94M |
| December 31, 2021 | 12.85M |
| December 31, 2020 | 0.7396M |
| Date | Value |
|---|---|
| December 31, 2019 | 8.072M |
| December 31, 2018 | 2.707M |
| December 31, 2017 | 7.258M |
| December 31, 2016 | 13.22M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.7396M
Minimum
2020
17.49M
Maximum
2023
11.02M
Average
12.85M
Median
2021
Revenue (Annual) Benchmarks
| United Therapeutics Corp | 2.328B |
| AIM ImmunoTech Inc | 0.202M |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 65.49M |
| Armata Pharmaceuticals Inc | -- |